Prostate cancer Board decisions

The Veteran's prostate and bladder cancers are presumed due to military environmental exposure, specifically Agent Orange. Service connection is granted for these conditions.,The Veteran's colon cancer and metastatic stomach cancer are also presumed due to military environmental exposure, specifically Agent Orange. Service connection is remanded for further review.

The Veteran's prostate cancer was granted service connection effective October 27, 2020.,Service connection for lumbosacral strain degenerative disc disease, intervertebral disc syndrome, and degenerative arthritis with spinal stenosis was granted effective December 30, 2016. The Veteran's radiculopathy of the right lower extremity (sciatic nerve) and left lower extremity (sciatic nerve), as well as his radiculopathy of the right lower extremity (femoral nerve) and left lower extremity (femoral nerve), were all granted service connection effective December 30, 2016.,The Veteran's prostate cancer is rated at 100% since October 27, 2020.

The Veteran's death prevented the appellant from filing a new claim for an earlier effective date based on clear and unmistakable error (CUE) in a prior rating decision. The appeal is denied.

The Veteran's claims for service connection for prostate cancer and hypertension, both claimed as due to herbicide exposure, have been denied. The evidence submitted does not support the presumption of herbicide exposure or establish a direct link between the conditions and military service.

The Veteran's prostate cancer and lung cancer are being remanded for further development as the Board found that there is insufficient evidence to establish a causal relationship between these conditions and his service, including exposure to contaminants at Camp Lejeune.

The Board denied the Veteran's claims for service connection for ischemic heart disease and prostate cancer, finding that there was no evidence of herbicide exposure or in-service injury/disease leading to these conditions.

The Board has remanded the case due to new legislation (PACT Act) requiring further research into the Veteran's exposure to herbicide agents, specifically if he visited Guam or other specified territories during his service.

The Board has reopened the Veteran's previously denied claim of service connection for prostate cancer and granted it, finding that new evidence supports a presumption of exposure to herbicides during service. The Veteran is now entitled to presumptive service connection for his prostate cancer.

The Board has decided to remand the case due to the need for further medical examination and opinion regarding the Veteran's claims of service connection for oral cancer, prostate cancer, and their relationship.

The Board denied service connection for prostate cancer, finding no evidence linking the condition to in-service exposure to radiation and rejecting the Veteran's claim based on lack of probative evidence.

The Veteran's service-connected disabilities, including prostate cancer, diabetes mellitus type II, peripheral neuropathy of the bilateral upper and lower extremities, tinnitus, erectile dysfunction, and left ear hearing loss, prevent him from securing and following a substantially gainful occupation. As his combined rating is at least 70 percent due to these conditions, he has been granted total disability evaluation based on individual unemployability (TDIU).

The Veteran's initial claims for higher ratings for prostate cancer and Von Willebrand disease were denied. The Board found that the evidence did not meet the criteria for a higher rating at any point during the appeal period.

The Board has granted service connection for tinnitus. The issues of service connection for bilateral hearing loss and prostate cancer due to herbicide exposure are remanded for further development.

The Veteran's claim for a higher rating for prostate cancer residuals was denied. The RO reduced the rating from 100% to 60%, effective August 1, 2016, based on lack of active malignancy and no recurrence or metastasis.

The Veteran's anxiety disorder is rated at 70 percent since February 14, 2017. The appeal for a higher rating prior to that date remains pending.,Prostate cancer has not been assigned any disability rating by the VA. The issue of entitlement to a compensable rating is remanded due to incomplete information in the March 2020 examination report.,The Veteran's TDIU claim is also remanded as it is inextricably intertwined with the prostate cancer rating issue.

The Veteran's service connection claims for diabetes mellitus, type II and prostate cancer status post surgery are granted due to exposure to herbicide agents during his service in Thailand.

The Board has remanded the claims for SMC and DEA eligibility due to new evidence of need for aid and attendance/housebound status, as well as a need for earlier effective date determination.

The Veteran's prostate cancer rating was reduced from 100% to 40%, effective June 1, 2020. The reduction was improper and the 100% rating is restored.,Service connection for PTSD was granted with an effective date of April 11, 2012, but no earlier.,SMC pursuant to 38 U.S.C. § 1114(s) from June 1, 2020, is granted.,SMC due to loss of use of a creative organ from December 12, 2019, is denied.,An initial compensable rating for erectile dysfunction is granted and an effective date earlier than December 12, 2019 is sought.,A higher rating for type II diabetes mellitus is requested.

The Veteran's claim for an earlier effective date for prostate cancer status post radical prostatectomy is denied as the evidence does not support a finding of entitlement prior to August 15, 2017.

The Veteran withdrew his appeal for a higher evaluation of prostate cancer, and the Board dismissed the case as a result.